NP5.DE

Newron Pharmaceuticals SpA [NP5.DE] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

NP5.DE Stock Summary

Top 10 Correlated Stocks

NP5.DE


In the News

NP5.DE Financial details

Company Rating
Neutral
Market Cap
0
Income
-18.91M
Revenue
6.28M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
26
Optionable
No
Shortable
Yes
Earnings
-
P/E
-6.87
Forward P/E
0
PEG
-2.65
P/S
17.78
P/B
32.97
P/C
-
P/FCF
-
Quick Ratio
9.47
Current Ratio
10.79
Debt / Equity
-3.65
LT Debt / Equity
-3.24
-
-
EPS (TTM)
-1.06
EPS next Y
1385.87
EPS next Q
-
EPS this Y
16.67%
EPS next Y
-131151.31%
EPS next 5Y
-131151.31%
EPS last 5Y
3.13%
Revenue last 5Y
8.65%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-5.4%
SMA50
141.3%
SMA100
351.52%
Inst Own
-
Inst Trans
-
ROA
-30%
ROE
-146%
ROC
-0.26%
Gross Margin
-
Oper. Margin
-214%
Profit Margin
-259%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.13-8.78
52W High
-28.25%
52W Low
+474%
RSI
49.98
Rel Volume
0.26
Avg Volume
11.06K
Volume
2.88K
Perf Week
-1.71%
Perf Month
-4.33%
Perf Quarter
325.19%
Perf Half Y
329.96%
-
-
-
-
Beta
-
-
-
Volatility
0.24%, 0.54%
Prev Close
0%
Price
5.74
Change
-3.04%

NP5.DE Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
0.230.390.290.320.34
Net income per share
-0.84-1.13-1.18-0.84-0.98
Operating cash flow per share
-0.9-1.24-0.87-0.64-0.62
Free cash flow per share
-0.9-1.25-0.88-0.64-0.62
Cash per share
2.462.191.751.941.28
Book value per share
3.072.060.970.17-0.79
Tangible book value per share
3.072.060.970.17-0.79
Share holders equity per share
3.072.060.970.17-0.79
Interest debt per share
00.981.62.582.78
Market cap
98.86M103.5M35.26M27.27M26.95M
Enterprise value
71.23M98.34M48.39M45.33M59.18M
P/E ratio
-6.58-5.12-1.68-1.83-1.54
Price to sales ratio
24.5614.716.714.734.42
POCF ratio
-6.14-4.66-2.26-2.38-2.43
PFCF ratio
-6.12-4.65-2.26-2.38-2.43
P/B Ratio
1.82.812.048.78-1.92
PTB ratio
1.82.812.048.78-1.92
EV to sales
17.713.979.27.879.71
Enterprise value over EBITDA
-4.78-5.07-2.82-3.86-4.44
EV to operating cash flow
-4.42-4.43-3.1-3.96-5.34
EV to free cash flow
-4.41-4.42-3.1-3.95-5.33
Earnings yield
-0.15-0.2-0.6-0.55-0.65
Free cash flow yield
-0.16-0.22-0.44-0.42-0.41
Debt to equity
0.090.641.9715.25-3.65
Debt to assets
0.080.390.660.941.38
Net debt to EBITDA
1.850.27-0.77-1.54-2.42
Current ratio
13.910.715.510.795.65
Interest coverage
-267.46-36.54-8.07-4.23-3.37
Income quality
1.071.10.740.770.63
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.280.910.940.610.58
Research and developement to revenue
1.231.711.971.861.97
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
-0.01-0.01-0.0100
Capex to depreciation
-0.85-0.25-0.16-0.1-0.09
Stock based compensation to revenue
0.520.30.280.130.08
Graham number
7.637.255.061.814.16
ROIC
-4.49-1.52-0.8211.73-1.58
Return on tangible assets
-0.25-0.34-0.41-0.3-0.47
Graham Net
2.180.88-0.15-0.72-1.59
Working capital
55.23M54.35M30.98M35.77M23.45M
Tangible asset value
54.81M36.8M17.25M3.11M-14.03M
Net current asset value
54.63M36.46M3.92M-7.95M-22.73M
Invested capital
00.461.5313.87-3.25
Average receivables
00000
Average payables
1.69M1.78M1.84M1.39M1.71M
Average inventory
2.5K0000
Days sales outstanding
00000
Days payables outstanding
305.67616.271.58K00
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
1.190.590.2300
Inventory turnover
00000
ROE
-0.27-0.55-1.22-4.81.25
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2022-12-31 for Q4

Metric History 2020-12-312021-06-302021-12-312022-06-30 2022-12-31
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
00000
Tangible book value per share
00000
Share holders equity per share
00000
Interest debt per share
00000
Market cap
00000
Enterprise value
13.13M15.55M18.06M25.58M32.24M
P/E ratio
00000
Price to sales ratio
00000
POCF ratio
00000
PFCF ratio
00000
P/B Ratio
00000
PTB ratio
00000
EV to sales
00000
Enterprise value over EBITDA
00000
EV to operating cash flow
00000
EV to free cash flow
00000
Earnings yield
00000
Free cash flow yield
00000
Debt to equity
1.973.5915.25-9.3-3.65
Debt to assets
0.660.780.941.121.38
Net debt to EBITDA
00000
Current ratio
5.57.910.798.845.65
Interest coverage
00000
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
00000
ROIC
00000
Return on tangible assets
00000
Graham Net
00000
Working capital
30.98M24.34M35.77M29.98M23.45M
Tangible asset value
17.25M8.69M3.11M-5.25M-14.03M
Net current asset value
3.92M-3.32M-7.95M-14.98M-22.73M
Invested capital
1.533.113.87-8.48-3.25
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
00000
Capex per share
00000

NP5.DE Frequently Asked Questions

What is Newron Pharmaceuticals SpA stock symbol ?

Newron Pharmaceuticals SpA is a IT stock , located in Bresso of Milano and trading under the symbol NP5.DE

What is Newron Pharmaceuticals SpA stock quote today ?

Newron Pharmaceuticals SpA stock price is $5.74 today.

Is Newron Pharmaceuticals SpA stock public?

Yes, Newron Pharmaceuticals SpA is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap